LONDON MARKET CLOSE: Miners drag down FTSE 100 into red
23rd Jul 2024 17:09
(Alliance News) - Stock prices in London closed lower on Tuesday, with the FTSE 100 dragged down by lower copper prices. Read More
(Alliance News) - Stock prices in London closed lower on Tuesday, with the FTSE 100 dragged down by lower copper prices. Read More
(Alliance News) - SkinBioTherapeutics PLC announced on Tuesday the closure of its convertible bond facility. Read More
(Alliance News) - SkinBioTherapeutics PLC announced on Tuesday the closure of its convertible bond facility. Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - SkinBioTherapeutics PLC on Friday said it saw its interim revenue soar on higher sales in the UK, as well as more returns across Europe, and affirmed that its full-year trading remains in line with guidance. Read More
(Alliance News) - SkinBioTherapeutics PLC on Monday said that it has begun a new research and development project in partnership with the University of Manchester. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - SkinBioTherapeutics PLC on Tuesday said its newly acquired Dermatonics will launch Pheet and Dermatonics Once Heel balm in Asia, the Middle East and Africa. Read More
SkinBioTherapeutics PLC - Newcastle, England-based life science company focused on skin health - Provides a trading update for the recently acquired Dermatonics Ltd, a Cambridgeshire-based manufacturer of skincare products. In January, SkinBio completed its acquisition of Dermatonics for an initial payment of GBP1.7 million, alongside a GBP1.3 million earn-out over three years. Dermatonics's revenue was GBP1.9 million for the year ended January 31, up 2.2% from GBP1.8 million a year prior. Earnings before interest, tax, depreciation and amortisation were GBP422,000 for the 12 months, up 77% from GBP230,000 adjusted Ebitda last year. Adjustments were a GBP150,000 stock write-off and GBP123,000 bad debt in financial 2023. As of January 31, Dermatonics had a cash balance of GBP149,000, down from GBP213,000. Read More
SkinBioTherapeutics PLC - Newcastle, England-based life science company focused on skin health - Completes the the acquisition of Dermatonics Ltd. On Thursday, it agreed to buy Dermatonics for GBP1.7 million initially, plus up to a GBP1.3 million earn-out over three years. St Ives, Cambridgeshire-based Dermatonics makes topical and dermatological products for skincare and woundcare, using natural ingredients wherever possible. It has annual earnings of GBP230,000 on GBP1.8 million in revenue. Read More
SkinBioTherapeutics PLC - Newcastle, England-based life science company focused on skin health - Agrees to acquire Dermatonics Ltd for GBP1.7 million initially, plus up to a GBP1.3 million earn-out over three years. St Ives, Cambridgeshire-based Dermatonics makes topical and dermatological products for skincare and woundcare, using natural ingredients wherever possible. It has annual earnings of GBP230,000 on GBP1.8 million in revenue. SkinBioTherapeutics says the acquisition will be financed with a GBP1.6 million drawdown from a new GBP5.0 million convertible bond issue. Read More
(Alliance News) - SkinBioTherapeutics PLC on Friday said it expects to complete an acquisition early in 2024, missing its year-end target. Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
SkinBioTherapeutics PLC - Newcastle, England-based life science company focused on skin health - Raises GBP3.0 million through placing of 15.9 million shares at 19 pence each. Says placing was completed through an accelerated bookbuild and was "materially oversubscribed". Placing price represents a 9.5% discount to SkinBio's closing middle market price of 21p per share on November 15, the day before it launched the placing. Company says the placing shares will be admitted to AIM on Wednesday and will represent around 9.2% of its total issued share capital. Read More
(Alliance News) - (Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More